Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1971 Apr;50(4):734–743. doi: 10.1172/JCI106544

Quantitative immunology of immune hemolytic anemia

II. The relationship of cell-bound antibody to hemolysis and the effect of treatment

Wendell F Rosse 1
PMCID: PMC291987  PMID: 16695957

Abstract

The concentration of cell-bound and serum antibody was determined in a series of patients with warm antibody immune hemolytic anemia by determining the amount of C[unk]1 fixed to the cells by anti-IgG. This was compared to the rate of hemolysis as determined by hemoglobin concentration and reticulocyte count, or the endogenous production of carbon monoxide. The rate of hemolysis was, in general, proportional to the concentration of cell-bound antibody. In splenectomized patients, the rate of hemolysis was very much less than in unsplenectomized patients for a given concentration of cell-bound antibody. When prednisone was given, three effects were noted: (a) at high doses of drug, the concentration of cell-bound antibody decreased rapidly and the concentration of serum antibody increased, suggesting that the affinity of antibody for antigen had been altered; (b) in patients achieving remission, the concentration of serum antibody fell to low levels but rose again if the dose of prednisone was insufficient; (c) in one patient, prednisone appeared to inhibit sequestration of highly sensitized cells.

Full text

PDF
734

Images in this article

738Image
on p.738
739Image
on p.739
740Image
on p.740
741Image
on p.741

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Archer G. T. Phagocytosis by human monocytes in red cells coated with Rh antibodies. Vox Sang. 1965 Sep-Oct;10(5):590–598. doi: 10.1111/j.1423-0410.1965.tb01413.x. [DOI] [PubMed] [Google Scholar]
  2. Borsos T., Rapp H. J. Complement fixation on cell surfaces by 19S and 7S antibodies. Science. 1965 Oct 22;150(3695):505–506. doi: 10.1126/science.150.3695.505. [DOI] [PubMed] [Google Scholar]
  3. CLINE M. J., BERLIN N. I. AN EVALUATION OF DFP AND CR AS METHODS OF MEASURING RED CELL LIFE SPAN IN MAN. Blood. 1963 Oct;22:459–465. [PubMed] [Google Scholar]
  4. CONSTANTOULAKIS M., COSTEA N., SCHWARTZ R. S., DAMESHEK W. QUANTITATIVE STUDIES OF THE EFFECT OF RED-BLOOD-CELL SENSITIZATION ON IN VIVO HEMOLYSIS. J Clin Invest. 1963 Nov;42:1790–1801. doi: 10.1172/JCI104864. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Coburn R. F., Williams W. J., Kahn S. B. Endogenous carbon monoxide production in patients with hemolytic anemia. J Clin Invest. 1966 Apr;45(4):460–468. doi: 10.1172/JCI105360. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. DAMESHEK W., ROSENTHAL M. C., SCHWARTZ L. I. The treatment of acquired hemolytic anemia with adrenocorticotrophic hormone (ACTH). N Engl J Med. 1950 Jan 25;244(4):117–127. doi: 10.1056/NEJM195101252440401. [DOI] [PubMed] [Google Scholar]
  7. DAVIDSOHN I. Immunohematological studies in hemolytic anemia. J Am Med Assoc. 1954 Mar 6;154(10):818–821. doi: 10.1001/jama.1954.02940440016004. [DOI] [PubMed] [Google Scholar]
  8. EVANS R. S., BINGHAM M., BOEHNI P. Autoimmune hemolytic disease. Antibody dissociation and activity. Arch Intern Med. 1961 Sep;108:338–352. doi: 10.1001/archinte.1961.03620090010003. [DOI] [PubMed] [Google Scholar]
  9. FUDENBERG H., BARRY I., DAMESHEK W. The erythrocyte-coating substance in autoimmune hemolytic disease: its nature and significance. Blood. 1958 Mar;13(3):201–215. [PubMed] [Google Scholar]
  10. GERMUTH F. G., Jr, OYAMA J., OTTINGER B. The mechanism of action of 17-hydroxy-11-dehydrocorticosterone (compound E) and of the adrenocorticotropic hormone in experimental hypersensitivity in rabbits. J Exp Med. 1951 Aug;94(2):139–170. doi: 10.1084/jem.94.2.139. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Gigli I., Nelson R. A., Jr Complement dependent immune phagocytosis. I. Requirements for C'1, C'4, C'2, C'3. Exp Cell Res. 1968 Jul;51(1):45–67. doi: 10.1016/0014-4827(68)90158-4. [DOI] [PubMed] [Google Scholar]
  12. Gilliland B. C., Leddy J. P., Vaughan J. H. The detection of cell-bound antibody on complement-coated human red cells. J Clin Invest. 1970 May;49(5):898–906. doi: 10.1172/JCI106309. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. JANDL J. H., KAPLAN M. E. The destruction of red cells by antibodies in man. III. Quantitative factors influencing the patterns of hemolysis in vivo. J Clin Invest. 1960 Jul;39:1145–1156. doi: 10.1172/JCI104129. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. KAPLAN M. E., JANDL J. H. Inhibition of red cell sequestration by cortisone. J Exp Med. 1961 Dec 1;114:921–937. doi: 10.1084/jem.114.6.921. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. LoBuglio A. F., Cotran R. S., Jandl J. H. Red cells coated with immunoglobulin G: binding and sphering by mononuclear cells in man. Science. 1967 Dec 22;158(3808):1582–1585. doi: 10.1126/science.158.3808.1582. [DOI] [PubMed] [Google Scholar]
  16. MOLLISON P. L., CROME P., HUGHES-JONES N. C., ROCHNA E. RATE OF REMOVAL FROM THE CIRCULATION OF RED CELLS SENSITIZED WITH DIFFERENT AMOUNTS OF ANTIBODY. Br J Haematol. 1965 Jul;11:461–470. doi: 10.1111/j.1365-2141.1965.tb06609.x. [DOI] [PubMed] [Google Scholar]
  17. RAPP H. J., BORSOS T. EFFECTS OF LOW IONIC STRENGTH ON IMMUNE HEMOLYSIS. J Immunol. 1963 Dec;91:826–832. [PubMed] [Google Scholar]
  18. Rosse W. F. Fixation of the first component of complement (C'la) by human antibodies. J Clin Invest. 1969 Nov;47(11):2430–2445. doi: 10.1172/JCI105926. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Rosse W. F. Quantitative immunology of immune hemolytic anemia. I. The fixation of C1 by autoimmune antibody and heterologous anti-IgG antibody. J Clin Invest. 1971 Apr;50(4):727–733. doi: 10.1172/JCI106543. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES